Literature DB >> 121869

Adult type GMl-gangliosidosis: a complementation study on somatic cell hybrids.

Y Suzuki, T Furukawa, A Hoogeveen, F Verheijen, H Galjaard.   

Abstract

Two adult siblings with progressive pyramidal and extrapyramidal lesions, and generalized muscle atrophy had a profound deficiency of beta-galactosidase in all the cells and body fluids examined. Neuraminidase activity was normal in fibroblasts. The fused fibroblasts of infantile GMl-gangliosidosis and each of these adult patients had beta-galactosidase activity as expected for the average value in a mixture of equal numbers of parental cells. However, there was a remarkable increase in the activity of beta-galactosidase when the cells from each of these cases were fused with those from the beta-galactosidase-deficient adult with cherry-red spots, cerebellar ataxia, myoclonus and neuraminidase deficiency in fibroblasts. It was concluded that the two siblings represent a new genetic variant (adult type) of GMl-gangliosidosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 121869     DOI: 10.1016/s0387-7604(79)80014-5

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.

Authors:  K Yoshida; A Oshima; M Shimmoto; Y Fukuhara; H Sakuraba; N Yanagisawa; Y Suzuki
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

2.  Autofluorescence emission spectra of neuronal lipopigment in a case of adult-onset ceroidosis (Kufs' disease).

Authors:  J H Dowson
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency.

Authors:  O P Van Diggelen; A W Schram; M L Sinnott; P J Smith; D Robinson; H Galjaard
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

4.  Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.

Authors:  Yoshiyuki Suzuki; Seiichiro Ogawa; Yasubumi Sakakibara
Journal:  Perspect Medicin Chem       Date:  2009-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.